Using this drug with ropinirole can increase the amount of ropinirole in your body.
Ropinirole should be titrated with caution in patients with hepatic disease.
Smoking is expected to increase the clearance of Ropinirole since CYP1A2 is known to be induced by smoking.
Ropinirole is a non-ergoline dopamine agonist. Use this medication regularly in order to get the most benefit from it. You and your healthcare provider should check your skin on a regular basis. For the reasons stated above, patients and providers are advised to monitor for melanomas frequently and on a regular basis when using REQUIP for any indication. You should not substitute REQUIP for REQUIP XL, or REQUIP XL for REQUIP without talking with your healthcare provider.
Ask your doctor before use if you are taking the following medications:
Several epidemiological trials have raised concerns of an increased risk of cancer associated with low total serum cholesterol levels that have been reproduced in a small number of randomized controlled statin trials.
Patients taking isoniazid should be monitored closely.
Advise patients to discontinue therapy and inform their physicians if any hearing loss symptoms occur.
If you already have similar urges, talk with your doctor about whether taking this drug is safe for you. Drug information contained herein may be time sensitive. You will need to talk about any risks to your baby. Ropinirole may cause an increase in irregular, jerky movements or uncontrolled body movements when it is taken with levodopa.